Azithromycin as an adjunctive treatment of aggressive periodontitis: Radiographic findings of a 12-month randomized clinical trial

Department of Periodontology, Faculty of Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
American journal of dentistry (Impact Factor: 0.85). 08/2012; 25(4):215-9.
Source: PubMed


To compare the 12-month radiographic outcomes following the use of azithromycin or placebo as adjuncts to non-surgical periodontal treatment of AgP.
17 aggressive periodontitis (AgP) subjects 13-26 years old were randomly assigned to receive scaling and root planing (SRP) with systemic azithromycin or placebo. Standardized radiographs were taken at baseline and 12 months postoperatively. Recall visits consisting of oral prophylaxis and oral hygiene instructions were performed during the 12 months. Digital image subtraction analysis and linear bone measurements were conducted by a blinded and calibrated examiner. Student t-tests were used for within and between-groups comparisons. ANCOVA was applied for between-group comparisons of changes in linear bone level adjusting for baseline values.
There were significant gains in linear bone levels in the azithromycin (0.55 +/- 0.10 mm) and placebo (0.42 +/- 0.07 mm) groups between the baseline and 12-month postoperative visits. There were also significant gains in bone density in the two treatment groups. No significant differences were observed between the two treatments in the amount of linear bone gain or bone density during the follow-up period. The use of azithromycin as an adjunct to SRP in the treatment of AgP did not result in significant radiographic bone level changes compared to placebo.

1 Follower
41 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Systemic antibiotics are often used as adjunctive treatment modalities for periodontal diseases. Testing of antimicrobial efficacy can be relevant only if the bacteria are in the form of biofilms rather than the planktonic state, and at concentrations of physiologic relevance, i.e., reachable in the periodontal pocket. The aim of the present study is to test the antimicrobial efficacy of five common antibiotic schemes at physiologically relevant concentrations on a multispecies in vitro biofilm model. Methods: A 10-species in vitro subgingival biofilm model was exposed to metronidazole (15 μg/mL), amoxicillin (15 μg/mL), metronidazole and amoxicillin in combination, doxycycline (2 μg/mL), and azithromycin (10 μg/mL) over 24 hours. Species-specific bacterial numbers were determined by culture on selective agar media or by epifluorescence microscopy. Results: Metronidazole alone did not affect biofilm composition. Total bacterial counts were significantly reduced by doxycycline, azithromycin, and amoxicillin alone or in combination with metronidazole, albeit by less than 1 log. On the species-specific level, these regimens significantly reduced the numbers of Streptococcus anginosus, Porphyromonas gingivalis, and Fusobacterium nucleatum, as well as Campylobacter rectus (except for amoxicillin alone). The strongest effects were displayed by the combination of amoxicillin and metronidazole. Conclusion: Antibiotics at concentrations detectable in gingival crevicular fluid do not dramatically reduce total bacterial loads in this in vitro biofilm model, but cause species-specific reductions, which may disrupt the biofilm unity.
    No preview · Article · May 2013 · Journal of Periodontology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective The purpose of this meta-analysis is to evaluate the effectiveness of different systemic antibiotics in combination with scaling and root planing (SRP) compared to SRP alone in patients with untreated aggressive periodontitis. Background In patients with aggressive periodontitis, SRP is often combined with the use of systemic antibiotics. However, the effectiveness of these antibiotics over time and differences in effectiveness between different antibiotics are hardly known. Material and Methods The MEDLINE-PubMed database was searched from their earliest records until January 20, 2014. Several journals were hand searched and some authors were contacted for additional information. The following outcome measures were analysed: mean probing pocket depth reduction, mean clinical attachment level gain and mean bleeding on probing change. Extracted data were pooled using a random effect model. Weighted mean differences were calculated and heterogeneity was assessed. ResultsThe search yielded 296 abstracts. Ultimately, 101 articles were selected of which 14 articles met the eligibility criteria. Systemic antibiotics showed a significant (p<0.05) additional pocket depth reduction for moderate (0.360.22mm at 3mo, 6mo 0.42 +/- 0.22mm and 12mo 0.88 +/- 0.27mm) and deep pockets (0.74 +/- 0.36mm at 3mo, 6mo 0.85 +/- 0.55mm and 12mo 1.26 +/- 0.81mm) and a significant clinical attachment gain for moderate (0.26 +/- 0.18 at 3mo, 6mo 0.52 +/- 0.15 and 12mo 0.83 +/- 0.38) and deep pockets (0.59 +/- 0.18 at 3mo, 0.96 +/- 0.21 at 6mo and 1.00 +/- 0.80 at 12mo). Conclusion For the treatment of patients with aggressive periodontitis, systemic antibiotics combined with non-surgical periodontal therapy resulted in a significant additional effect compared to non-surgical therapy alone. There is a visible trend that showed metronidazole+amoxicillin is the most potent antibiotic combination.
    Full-text · Article · Aug 2014 · Journal of Periodontal Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: The occurrence of periodontal disease in the population is on the increase and the therapeutic means combine conventional mechanic treatment with antibiotics and guided tissue regeneration and guided osseous regeneration. The most frequently used antibiotics are penicillins and tetracyclines and their derivatives. Unfortunately, the occurrence of allergic reactions especially to penicillins, as well as the steadily growing bacterial resistance require the choice of new alternative antibiotics active on the mainly Gram-negative anaerobic strains. Azithromycin is a new generation macrolide mainly used in respiratory tract infections and in urogenital infections, but it has pharmacokinetic properties such as tissular penetration and it is readily taken up by neutrophils, macrophages and fibroblasts and antiinflammatory effects which recommend it for treatment of periodontal disease. Computerised research of PubMed-NCBI resources, EBSCO Dentistry & Oral Sciences Sources, EBSCO Discovery Service and Ovid MEDLINE(R) resources has shown that there are relatively few clinical and microbiological studies on azithromycin as compared to the number of studies on the other antibiotics used in the treatment of periodontal disease. However, they are relevant for the efficacy of including azithromycin in periodontal treatment.
    No preview · Article · Mar 2015 · Romanian Biotechnological Letters